Unlock instant, AI-driven research and patent intelligence for your innovation.

A kind of preparation method of pharmaceutical intermediate compound

A compound and mixture technology, applied in the field of preparation of pharmaceutical intermediate compounds, can solve the problems of limited application, unsuitability for large-scale industrial synthetic compounds, low yield of intermediate compounds, etc., and achieve low toxicity of raw materials, simple and efficient industrialization , low cost effect

Active Publication Date: 2022-06-28
德琪(浙江)医药科技有限公司
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] Because the yields of intermediate compounds shown in formula T541-C and T541-D are not high, the existing preparation method is not suitable for large-scale industrial synthesis of compounds shown in formula T541, which limits the use of compounds shown in formula T541 in pharmaceutical preparation and clinical practice. app in development

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of preparation method of pharmaceutical intermediate compound
  • A kind of preparation method of pharmaceutical intermediate compound
  • A kind of preparation method of pharmaceutical intermediate compound

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0051] The preparation of embodiment 1 compound T541-B

[0052]

[0053] Table 1: Bill of Materials for Preparation of T541-B

[0054]

[0055] The preparation steps of T541-B include the following operations:

[0056] (1) Reaction

[0057] Add 50 grams of T541-RM1 and 650 grams of toluene to the kettle. The reaction mixture was cooled to -70~-60°C, and 61.5 g of 2.5M n-butyllithium was slowly added dropwise at a temperature of -70~-55°C. Stir at a temperature of -70 to -55°C for 3-5 hours, and then take a sample for in-process analysis (IPC analysis) (indicator: T541-RM1≤3.0%), showing that there is no T541-RM1 residue. 15 g of acetone was slowly added dropwise to the reaction mixture at a temperature of -70 to -50°C. The mixture was stirred at a temperature of -70 to -50°C for 0.5 to 1.5 hours.

[0058] (2) Quenching

[0059] Add about 11.5% by weight ammonium chloride aqueous solution (prepared from 50 grams of water and 6.5 grams of salt) to the reaction mixt...

Embodiment 2

[0095] Preparation of Example 2 T541-C

[0096]

[0097] Table 7: Bill of Materials for Preparation of T541-C

[0098]

[0099] The preparation steps of T541-C include the following operations:

[0100] (1) Reaction

[0101] 45.61 g of T541-B in toluene and 21.56 g of imidazole were added to the reaction kettle. Adjust the temperature of the reaction mixture to 10-20° C., control the temperature at 10-20° C., and slowly add 29.11 g of trimethylchlorosilane dropwise. After the dropwise addition, continue to stir at a temperature of 20-30° C. for 10-15 hours. Samples were taken for in-process analysis (standard: T541-B≤1.0%), which showed no T541-B residue.

[0102] (2) Quenching

[0103] Cool the reaction mixture obtained in step (2) to 10-20° C., then add 200 grams of water into the reaction mixture at a temperature of 10-30° C., and stir for 20-40 minutes at the same temperature. After standing for 30-60 minutes, the layers are separated, the water phase at the ...

Embodiment 3

[0116] Example 3 Preparation of T541-D

[0117]

[0118] Table 9: Bill of Materials for Preparation of T541-D

[0119]

[0120]

[0121] The preparation steps of T541-D include the following operations:

[0122] (1) Reaction

[0123] The reactor was inertized 3 times with nitrogen, and 60.84 grams of T541-C solution, 450 grams of 1,4-dioxane, 62.14 grams of potassium acetate, and 53.60 grams of pinacol diborate ((BPIN) 2 ) and 1.85 g of 1,1-bis(diphenylphosphino)ferrocenepalladium dichloride (PdCl 2 (dppf)) into the reactor. Heat to 80-90°C and stir at this temperature for 10-15 hours. Sampling analysis (standard: T541-C≤0.5%) showed no T541-C residue.

[0124] (2) The first filter

[0125] Cool the reaction mixture obtained in step (1) to 15-25°C. The reaction mixture was filtered and the filter cake was washed twice with 91 g of 1,4-dioxane.

[0126] (3) The first concentration

[0127] Concentrate the filtrate obtained in step (2) in vacuum at a temperat...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides a preparation method of a pharmaceutical intermediate compound, which comprises: reacting a compound represented by formula T541-RM1 with acetone in an organic solvent in the presence of a base to generate a compound represented by formula T541-B; Add the base to the mixture of the compound represented by the formula T541-RM1 and the organic solvent at ~-55°C, and then add acetone to react, and the molar ratio of the compound represented by the formula T541-RM1, acetone and the base is 1.0:1.0~2.0:1.0 ~1.1; Compound shown in formula T541-B reacts with trimethylchlorosilane in organic solvent in the presence of alkali to generate compound shown in formula T541-C; Compound shown in formula T541-C is in organic solvent in 1,1- In the presence of bis(diphenylphosphino)ferrocene palladium dichloride and acetate, it reacts with biboronic acid pinacol ester to generate the compound shown in formula T541-D. The preparation method is simple in operation, strong in controllability, does not require harsh reaction conditions, has high selectivity, can be directly used in subsequent reactions without separation, has low raw material toxicity and low cost, and is very suitable for pharmaceutical industry production.

Description

technical field [0001] The invention belongs to the field of chemical pharmacy, and in particular relates to a preparation method of a drug intermediate compound represented by formula T541. [0002] Background technique [0003] The chemical name of the compound shown in formula T541 is 2-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl ) Propan-2-ol hydrochloride, the molecular formula is C 14 h 23 BClNO 3 , the molecular weight is 299.60. Studies have shown that this substance is an important intermediate for the introduction of aromatic substituents in the synthesis of many anti-tumor drugs, among which common anti-tumor drugs such as mTORC1 and mTORC2 target inhibitors. [0004] Chinese invention patent application CN104093398A discloses the preparation method of the compound shown in formula 10, that is, the compound shown in formula T541, which adopts the following synthetic route: [0005] [0006] Wherein, the yield of the intermediate compoun...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07F7/18C07F5/02
CPCC07F7/1804C07F7/188C07F5/025
Inventor 王峥王岭单波何旭东沈海均康理范海霞
Owner 德琪(浙江)医药科技有限公司